David Wexler to Glucose
This is a "connection" page, showing publications David Wexler has written about Glucose.
Connection Strength
0.023
-
Devineni D, Curtin CR, Marbury TC, Smith W, Vaccaro N, Wexler D, Vandebosch A, Rusch S, Stieltjes H, Wajs E. Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor. Clin Ther. 2015 Mar 01; 37(3):610-628.e4.
Score: 0.023